Antiphospholipid autoantibodies as blood biomarkers for detection of early stage Alzheimer’s disease

References

• Alzheimer’s disease facts and figures. 2014. Alzheimers Dement. 10: 1–76
   Google Scholar
• Alkalay, A., G. D. Rabinovici, G. Zimmerman, et al. 2013. Plasma acetylcholinesterase activity correlates with intracerebral beta-amyloid load. Curr. Alzheimer Res. 10: 48–56
   PubMed Web of Science ®Google Scholar
• Alsadany, M. A., H. H. Shehata, M. I. Mohamad, and R. G. Mahfouz. 2013. Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 28: 54–61
   PubMed Web of Science ®Google Scholar
• Bai, L., N. Song, J. Yu, et al. 2013. Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer's disease patients of Northern Han Chinese descent. Curr. Alzheimer Res. 10: 57–62
   PubMed Web of Science ®Google Scholar
• Honma, T., K. Hatta, Y. Hitomi, et al. 2013. Increased systemic inflammatory interleukin-1ss and interleukin-6 during agitation as predictors of Alzheimer's disease. Int. J. Geriatr. Psychiatry 28: 233–241
   PubMed Web of Science ®Google Scholar
• Liang, F., J. Jia, S. Wang, et al. 2013. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease. J. Clin. Neurosci. 20: 357–361
   PubMed Web of Science ®Google Scholar
• Lopez, N., C. Tormo, I. De Blas, et al. 2013. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J. Alzheimers Dis. 33: 823–829
   PubMed Web of Science ®Google Scholar
• Huang, C. W., S. J. Wang, S. J. Wu, et al. 2013. Potential blood biomarker for disease severity in the taiwanese population with Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen. 28: 75–83
   PubMed Web of Science ®Google Scholar
• May, J. E., R. M. Pemberton, J. P. Hart, et al. 2013. Use of whole blood for analysis of disease-associated biomarkers. Anal. Biochem. 437: 59–61
   PubMed Web of Science ®Google Scholar
• Leung, R., P. Proitsi, A. Simmons, et al. 2013. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease. PLoS One 8: e64971
   Google Scholar
• Laske, C., M. Schmohl, T. Leyhe, et al. 2013. Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients. J. Alzheimers Dis. 34: 367–375
   PubMed Web of Science ®Google Scholar
• Ray, S., M. Britschgi, C. Herbert, et al. 2007. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13: 1359–1362
   PubMed Web of Science ®Google Scholar
• O'Bryant, S. E., G. Xiao, R. Barber, et al. 2011. A blood-based algorithm for the detection of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 32: 55–62
   PubMed Web of Science ®Google Scholar
• Soares, H. D., W. Z. Potter, E. Pickering, et al. for the Biomarkers Consortium Alzheimer's Disease Plasma Proteomics. 2012. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer Disease. Arch. Neurol. 69:1–8
   Google Scholar
• Doecke, J. D., S. M. Laws, N. G. Faux, et al. 2012. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch. Neurol. 69: 1318–1325
   PubMedGoogle Scholar
• Ray, L., V. K. Khemka, P. Behera, et al. 2013. Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia. Aging Dis. 4: 57–64
   PubMed Web of Science ®Google Scholar
• Hye, A., J. Riddoch-Contreras, A. L. Baird, et al. 2014. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. 6: 799–807
   Google Scholar
• Cheng, L., R. A. Sharples, B. J. Scicluna, and A. F. Hill. 2014. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J. Extracell. Vesicles 3. doi: 10.3402/jev.v3.23743
   Google Scholar
• Bekris, L. M., F. Lutz, T. J. Montine, et al. 2013. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers: Biochem. Indicat. Exposure Response Suscept. Chem. 18: 455–466
   Google Scholar
• Fiandaca, M. S., D. Kapogiannis, M. Mapstone, et al. 2014. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. doi:10.1016/j.jalz.2014.06.008
   Google Scholar
• Kapogiannis, D., A. Boxer, J. B. Schwartz, et al. 2014. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease. FASEB J. doi:10.1096/fj.14-262048
   Google Scholar
• Bruce-Keller, A. J., S. Gupta, T. E. Parrino, et al. 2010. NOX activity is increased in mild cognitive impairment. Antioxid. Redox. Signal. 12: 1371–1382
   PubMed Web of Science ®Google Scholar
• Smith, M. A., X. Zhu, M. Tabaton, et al. 2010. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19: 363–372
   PubMed Web of Science ®Google Scholar
• Padurariu, M., A. Ciobica, L. Hritcu, et al. 2010. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 469: 6–10
   PubMed Web of Science ®Google Scholar
• Lavados, M., M. Guillon, M. C. Mujica, et al. 2008. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J. Alzheimers Dis. 13: 225–232
   PubMed Web of Science ®Google Scholar
• Levin, E. C., N. K. Acharya, M. Han, et al. 2010. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown. Brain Res. 1345: 221–232
   PubMed Web of Science ®Google Scholar
• Koehler, N. K., E. Stransky, M. Shing, et al. 2013. Altered serum IgG levels to alpha-synuclein in dementia with lewy bodies and Alzheimer's disease. PLoS One 8: e64649
   Google Scholar
• Gnanapavan, S., D. Grant, G. Pryce, et al. 2012. Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis. Autoimmunity 45: 298–303
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., D. R. Wagenknecht, and W. P. Faulk. 2006. Redox-reactive autoantibodies: detection and physiological relevance. Autoimmun. Rev. 5: 76–83
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., D. R. Wagenknecht, and W. P. Faulk. 2005. Autoantibodies unmasked by redox reactions. J. Autoimmun. 24: 311–317
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., D. R. Wagenknecht, and C. J. Ramsey. 2009. Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls. Autoimmunity 42: 646–652
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., J. Chapman, E. Shavit, R. L. Hamilton, and S. T. Dekosky. 2007. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies. Autoimmunity 40: 390–396
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., R. L. Hamilton, and S. T. DeKosky. 2007. Redox-reactive autoantibodies in cerebrospinal fluids. Ann. N. Y. Acad. Sci. 1109: 296–302
   PubMed Web of Science ®Google Scholar
• Li, S. D., Y. D. Su, M. Li, and C. G. Zou. 2006. Hemin-mediated hemolysis in erythrocytes: effects of ascorbic acid and glutathione. Acta Biochim. Biophys. Sin. 38: 63–69
   Google Scholar
• McIntyre, J. A., D. R. Wagenknecht, and W. P. Faulk. 2003. Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog. Lipid Res. 42: 176–237
   PubMed Web of Science ®Google Scholar
• Nishida, T., and F. A. Kummerow. 1962. Interaction of low-density lipoproteins of serum with hemin. J. Lipid Res. 3: 448–455
   Web of Science ®Google Scholar
• Agar, C., G. M. van Os, M. Morgelin, et al. 2010. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116: 1336–1343
   PubMed Web of Science ®Google Scholar
• Sugi, T., and J. A. McIntyre. 1995. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 86: 3083–3089
   PubMed Web of Science ®Google Scholar
• McIntyre, J. A., D. R. Wagenknecht, and T. Sugi. 1997. Phospholipid binding plasma proteins required for antiphospholipid antibody detection – an overview. Am. J. Reprod. Immunol. 37: 101–110
   PubMed Web of Science ®Google Scholar
• Zar, J. H. 1999. Biostatistical Analysis. Prentice-Hall, Inc., Upper Saddle River, New Jersey
   Google Scholar
• Hall, M., F. Eibe, B. Holmes, et al. 2009. The WEKA data mining software: an update. SIGKDD Explor. 11: 10–18
   Google Scholar
• Breiman, L., J. Friedman, R. Olshen, and C. Stone. 1984. Classification and Regression Trees. Wadsworth Publishing Co., Pacific Grove, CA
   Google Scholar
• Dimitrov, J. D., L. T. Roumenina, V. R. Doltchinkova, et al. 2007. Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J. Biol. Chem. 282: 26696–26706
   PubMed Web of Science ®Google Scholar
• Gonzalez-Dominguez, R., T. Garcia-Barrera, and J. L. Gomez-Ariza. 2014. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease. J. Proteomics 104: 37–47
   PubMed Web of Science ®Google Scholar
• Ravichandran, K. S. 2010. Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J. Exp. Med. 207: 1807–1817
   PubMed Web of Science ®Google Scholar
• Mapstone, M., A. K. Cheema, M. S. Fiandaca, et al. 2014. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20: 415–418
   PubMed Web of Science ®Google Scholar
• González-Domínguez, R., T. García-Barrera, and J. L. Gómez-Ariza. 2014. Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry. J. Pharm. Biomed. Anal. 98: 321–326
   PubMed Web of Science ®Google Scholar
• Gonzalez-Dominguez, R., T. Garcia-Barrera, and J. L. Gomez-Ariza. 2014. Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease. Anal. Bioanal. Chem. 406: 7137–7148
   PubMed Web of Science ®Google Scholar
• Nagele, E., M. Han, C. Demarshall, et al. 2011. Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera. PLoS One 6: e23112
   PubMed Web of Science ®Google Scholar
• Maftei, M., F. Thurm, C. Schnack, et al. 2013. Increased levels of antigen-bound beta-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients. PLoS One 8: e68996
   PubMed Web of Science ®Google Scholar